RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study aims to Fine-Tune infection shield for myeloma patients
Disease control Recruiting nowThis study aims to find the best level of protective antibodies to give patients with hard-to-treat multiple myeloma who are receiving a new type of immunotherapy. The new treatment can weaken the immune system, raising the risk of serious infections. Researchers are comparing wh…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE4 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Four-Drug attack on Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a new combination of four medications for people whose multiple myeloma has come back or stopped responding to prior treatments. The main goal is to see if this combination can shrink the cancer so effectively that it becomes undetectable by very sensitive t…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Benjamin T Diamond, MD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for patients who have run out of options
Disease control Recruiting nowThis early-stage study is testing a new combination of three drugs for patients with multiple myeloma that has come back or stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see how well the combination works. The tria…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Alfred Chung, MD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC